Related Experiment Video
Updated: May 1, 2026
A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Increased expression of CXCR3 axis components and matrix metalloproteinase in pediatric inflammatory bowel disease
Keisuke Jimbo1, Yoshikazu Ohtsuka1, Yuko Kojima2
1Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Insights
Researchers investigated pediatric inflammatory bowel disease (IBD) pathogenesis. They found elevated CXCL9, 10, 11, and matrix metalloproteinase (MMP) expression in active pediatric IBD, suggesting their role in mucosal damage.
Area of Science:
- Gastroenterology
- Immunology
- Pediatric Medicine
Background:
- Pediatric inflammatory bowel disease (IBD) presents with extensive intestinal involvement and rapid progression.
- The exact causes and aggravating factors in pediatric IBD remain unclear.
- Understanding IBD pathogenesis is crucial for effective treatment strategies.
Purpose of the Study:
- To investigate the underlying pathogenesis of pediatric inflammatory bowel disease (IBD).
- To identify key molecular factors contributing to disease aggravation in children.
- To explore the role of specific inflammatory molecules in IBD.
Main Methods:
- Compared inflammatory molecule expression in colon samples from active/remission pediatric ulcerative colitis (UC) and Crohn's disease (CD) patients versus controls.
- Utilized microarray analysis to examine inflammatory gene expression in mucosal tissues.
- Employed real-time reverse transcription polymerase chain reaction and immunohistochemistry to validate and assess specific protein expression (CXCL9-11, CXCR3, MMP-1, -3, -7, -10).
Main Results:
- Microarray analysis showed increased CXCL9, 10, and 11 gene expression in active CD.
- Significantly enhanced expression of MMP-1, -3, -7, and -10 was observed in active UC.
- Immunohistochemistry confirmed elevated CXCL9, 10, 11, and MMPs in both epithelial and lamina propria cells in active pediatric IBD patients.
Conclusions:
- The CXCR3 axis components (CXCL9, 10, 11, CXCR3) are implicated in pediatric IBD.
- Matrix metalloproteinases (MMPs) play a significant role in mucosal damage in pediatric IBD.
- These molecular pathways are critical targets for understanding and potentially treating pediatric IBD.
Background:
Although pediatric inflammatory bowel disease (IBD) is characterized by extensive intestinal involvement and rapid early progression, the precise cause and specific factors involved in disease aggravation have not been well established. The aim of this study was to investigate the pathogenesis of pediatric IBD.
Methods:
The expression of inflammatory molecules in colon samples taken from active ulcerative colitis (UC) and Crohn's disease (CD) patients was compared with those of controls. Three children each with UC and CD in both the active and remission phase and their controls were enrolled, and the inflammatory gene expression in the mucosa was examined by microarray. Additionally, six children from each group were further enrolled in a real-time reverse transcription polymerase chain reaction and an immunohistochemical study to examine the expression of CXCL9, 10, 11, CXCR3, matrix metalloproteinase (MMP)-1, -3, -7, and -10.
Results:
The microarray analysis revealed enhanced expression of the CXCL9, 10, and 11 genes in the active phase of CD. The expression of MMP-1, -3, -7, and -10 was significantly enhanced in the active phase of UC. These changes were also confirmed by real-time reverse transcription polymerase chain reaction. Immunohistochemical analysis revealed enhanced expression of CXCL9, 10, and 11 in both the lamina propria and epithelial cells in these patients. CXCR3-positive cells were also confirmed in the lamina propria. The expression of MMP-1, -3, -7, and -10 was also enhanced in the mucosal epithelial cells and the lamina propria in both CD and UC patients.
Conclusions:
These findings suggest that CXCR3 axis components and MMP play an important role in the mucosal damage in pediatric IBD.
More Related Videos
06:31Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
Published on: June 2, 2023
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction